Company intelligence / Profile preview

Sanford Biosciences

Sioux Falls, South Dakota, United States

Ownership: Private
Development stage: Other

Overview

Sanford Biosciences (formerly Sanford Applied Biosciences) develops and researches an animal-based platform for generating fully human antibodies and acts as a life science investor; there is no public evidence of clinical-stage internal therapeutics.[1][3]

Modalities: Monoclonal antibodyBiologic
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Sanford Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanford Biosciences.

Explore the full profile